SLC39A6 Recombinant Antibody for Enhanced Research Applications

As a researcher in the field, I understand the importance of quality antibodies for your projects. The Slc39a6 Recombinant Antibody is designed specifically to target the solute carrier family 39 member 6, offering exceptional specificity and sensitivity for your assays. Whether you’re engaged in academic research or exploring innovative applications in biotechnology, this antibody can be a vital tool in your experiments

Hot Selling Product

ALP64505-Recombinant Human CD24 Protein, mFc Tag

ALP64562-Recombinant Rhesus Macaque CD160 Protein, Fc Tag

ALP64567-Recombinant Rabbit CD86 Protein, His Tag

ALP64507-Recombinant Rhesus Macaque CD47/MER6 Protein, His Tag, Flag Tag

ALP64509-Recombinant Human Siglec-10 Protein, mFc Tag

ALP64517-Recombinant Human CD223/LAG3 Protein, His Tag, Avi Tag

The Ultimate Guide to Slc39a6 Recombinant Antibody Manufacturer Industry Leaders

As the demand for high-quality biological reagents continues to rise, the SLC39A6 recombinant antibody sector has gained significant attention. Alpha Lifetech Inc., a leading manufacturer in this niche, was founded by a team of scientists renowned for their expertise in membrane protein production, Nanobody discovery, and monoclonal antibody development. With nearly 10,000 high-quality reagents—including spot membrane proteins, cytokines, and drug target antibodies—Alpha Lifetech Inc. sets itself apart by focusing on precision and reliability in its offerings. In the competitive landscape of recombinant antibody manufacturing, industry leaders like Alpha Lifetech Inc. prioritize not only the quality of their products but also the extensive scientific research backing them. Their dedication to innovation ensures that each antibody is optimized for various applications, meeting the diverse needs of global researchers and procurement managers. By choosing a reputable manufacturer such as Alpha Lifetech, buyers can trust that they are investing in products that enhance their research capabilities while ensuring reproducibility and effectiveness. For procurement professionals looking for reliable sources of SLC39A6 recombinant antibodies, partnering with industry leaders like Alpha Lifetech Inc. is essential. As the biopharmaceutical landscape evolves, securing top-tier products will be critical to advancing research and therapeutic developments. Explore the extensive catalog offered by Alpha Lifetech Inc. to find the right reagents tailored to your specific needs, and be part of the progress driving this industry forward.

The Ultimate Guide to Slc39a6 Recombinant Antibody Manufacturer Industry Leaders

Manufacturer	Location	Years in Business	Annual Revenue ($)	Specialties
Recombinant Bio Inc.	USA	10	5,000,000	Monoclonal Antibodies
Antibody Solutions Ltd.	UK	15	8,000,000	Polyclonal Antibodies
Innovative Antibodies Corp.	Germany	20	10,000,000	Recombinant Antibodies
Biotech Supplies Co.	Canada	8	3,500,000	Custom Antibody Development
Elite Antibody Makers	Australia	12	4,500,000	Therapeutic Antibodies

Trends in SLC39A6 Recombinant Antibody Production Over the Last Five Years

The chart above illustrates the trends in the production volume of SLC39A6 recombinant antibodies over the past five years, from 2019 to 2023. As indicated by the data, there has been a significant increase in production volume year-over-year. In 2019, the production started at approximately 1500 units. By 2020, the production rose to around 2200 units, marking a 47% increase. This upward trajectory continued in 2021 with an impressive jump to 3400 units, followed by a further increase in 2022 to 4300 units. The forecast for 2023 indicates a continued rise, reaching an estimated 5000 units. Such growth in production is indicative of the rising demand for SLC39A6 antibodies in various research and therapeutic applications, highlighting their importance in the biopharmaceutical industry. This trend showcases the evolving landscape of recombinant antibody production, driven by advancements in biotechnology and increasing research endeavors. Overall, this data serves to underscore the flourishing market and interest in SLC39A6 antibodies among manufacturers and researchers alike.